×

Cigna raises annual profit forecast on strength in health services unit

By Thomson Reuters Nov 5, 2026 | 5:03 AM

By Sneha S K, Kunal Das and Amina Niasse

Nov 5 (Reuters) – Cigna on Thursday raised its annual profit forecast after beating third-quarter estimates, driven by growth in its US health insurance business, specialty pharmacy and health services.

The company also said it expects ​its adjusted profit to grow at least 10% in 2027.

“We have a clear strategic ‌growth framework for creating long-term value and will continue to execute with discipline,” said CEO Brian Evanko.

Evernorth Health Services, which includes Cigna’s pharmacy-benefit, specialty-pharmacy and care-services businesses, posted adjusted revenue of $63.77 billion in the third quarter, up about 6% from a year earlier.

Profit for specialty pharmacy and care services grew 15% during the quarter to $1.06 billion, while ‌its ​pharmacy benefit services division saw profit fall 22% to $765 million.

The company’s ⁠healthcare unit, which includes its ⁠fee-based business of managing corporate-sponsored health plans and includes Affordable Care Act plans, reported adjusted revenue of $11.71 billion, up about 9% from a year ago.

“The insurance business drove the results, and medical costs, while still elevated, were in line with what Cigna had priced for. Specialty ​pharmacy remains a source of growth,” said Daniel Barasa, portfolio manager at Gabelli.

Its medical loss ratio, or the percentage of premiums spent on patient care, rose to 85% in the third quarter ⁠from 84.8% a year earlier, due to changes in ⁠its US-employer insurance business. The loss ratio affects its margins on ACA ​plans.

Analysts had expected a medical cost ratio of 85.18%, according to data compiled by LSEG.

Cigna exited its ​Medicare Advantage business last year, and plans to exit ACA coverage at the end ‌of 2026.

The company in September announced a new program that aims to deliver about $3 billion in cost savings by 2030. The program will focus on streamlining workflows with AI-enabled insights and tools.

The company said it expects a boost to customer growth and margin improvement in certain employer-backed plans next ⁠year, even as it faces other challenges, including those arising from its exit from the ACA market, lower drug rebates, reduced employer coverage of weight-loss drugs and fewer launches of lower-cost versions of specialty ⁠medicines.

Julie Utterback, an analyst at Morningstar, ‌said costs associated with Cigna’s transition to a fee-based model from ⁠a rebate model for its pharmacy benefit business are largely being incurred ​this year, ‌which could help profit growth pick up in 2027.

The company said ​it is actively ⁠transitioning contracts with drugmakers and network pharmacies.

Cigna now expects 2026 adjusted profit of at least $30.60 per share, 15 cents higher than its previous forecast and above analysts’ expectations of $30.51.

Its quarterly adjusted revenue of $73.79 billion beat analysts’ estimates of $72.72 billion, while adjusted profit of $7.98 per share exceeded market consensus of $7.50.

(Reporting by Kunal Das and Sneha S K in Bengaluru; Reporting by Amina Niasse in New York; Editing by Shinjini ​Ganguli and Tasim Zahid)